Ema
Ema is an AI platform designed specifically for women's health and wellness, aiming to redefine care for companies serving women. It offers an intelligence layer for technologies, providing personalized AI support for improved outcomes and engagement across diagnostics to wellness products. Ema is purpose-built, evidence-backed, and doctor-vetted, trained on over 10 million real conversations with women and grounded in nursing and biopsychosocial models. It claims to save $500K compared to custom builds, offer 90% faster deployment than in-house AI, and has shown success in encouraging users to talk to doctors and seek care for conditions like depression. Key partnerships include PatientsLikeMe, integrating Ema's AI for chronic care navigation and medication adherence, and Willow for postpartum support and product recommendations.
Ema
Ema is an AI platform designed specifically for women's health and wellness, aiming to redefine care for companies serving women. It offers an intelligence layer for technologies, providing personalized AI support for improved outcomes and engagement across diagnostics to wellness products. Ema is purpose-built, evidence-backed, and doctor-vetted, trained on over 10 million real conversations with women and grounded in nursing and biopsychosocial models. It claims to save $500K compared to custom builds, offer 90% faster deployment than in-house AI, and has shown success in encouraging users to talk to doctors and seek care for conditions like depression. Key partnerships include PatientsLikeMe, integrating Ema's AI for chronic care navigation and medication adherence, and Willow for postpartum support and product recommendations.
TL;DR
Sector: Women's health AI platform
Stage / funding: Seed; ~$2.75M total reported
Team size (reported): 4 employees
Key claims: Doctor-vetted, trained on >10M conversations; faster & cheaper than custom builds
Company Overview
Problem Domain
Women's health and wellness; chronic care navigation and engagement
Industry
Healthtech
Funding Track Record
Closed Jan 7, 2025 per funding record; investors also listed include Victorum Capital and Kubera Venture Capital.